Clinical Trial Update: A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers [Phase 1]

View source ↗

Summary

Early-phase trial assessing safety and pharmacologic activity of BT200 in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Stroke
• Intracranial Arteriosclerosis
• Large-artery Atherosclerosis

Drugs mentioned

• BT200 (Rondaptivon Pegol)

Snippet

Sponsor: Band Therapeutics | Conditions: Cerebrovascular Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis) | Phase 1 | Status: COMPLETED | Results posted: 2024-03-18